364 related articles for article (PubMed ID: 4037939)
1. Factors influencing erythrocyte sedimentation in patients with chronic renal failure.
Shusterman N; Kimmel PL; Kiechle FL; Williams S; Morrison G; Singer I
Arch Intern Med; 1985 Oct; 145(10):1796-9. PubMed ID: 4037939
[TBL] [Abstract][Full Text] [Related]
2. Comparison of zeta sedimentation ratio with Westergren sedimentation rate.
Saleem A; Jafari E; Yapit MK
Ann Clin Lab Sci; 1977; 7(4):357-60. PubMed ID: 900862
[TBL] [Abstract][Full Text] [Related]
3. The significance of extreme elevation of the erythrocyte sedimentation rate in hemodialysis patients.
Al-Homrany M
Saudi J Kidney Dis Transpl; 2002; 13(2):141-5. PubMed ID: 17660652
[TBL] [Abstract][Full Text] [Related]
4. The erythrocyte sedimentation rate, C-reactive protein, plasma fibrinogen and viscosity in chronic renal disease patients with infection.
Ishak R; Hassan K
Malays J Pathol; 1989 Aug; 11():29-31. PubMed ID: 2632997
[TBL] [Abstract][Full Text] [Related]
5. The erythrocyte sedimentation rate in end-stage renal failure.
Bathon J; Graves J; Jens P; Hamrick R; Mayes M
Am J Kidney Dis; 1987 Jul; 10(1):34-40. PubMed ID: 3605082
[TBL] [Abstract][Full Text] [Related]
6. Effect of anti-HCV positivity on markers of malnutrition and inflammation in hemodialysis patients.
Zumrutdal A; Ozer B; Singan M; Micozkadioglu H; Sezer S; Ozdemir FN; Haberal M
Ren Fail; 2007; 29(1):85-90. PubMed ID: 17365915
[TBL] [Abstract][Full Text] [Related]
7. Zeta sedimentation ratio in rheumatic disease. Comparison of the zeta sedimentation ratio with the Wintrobe and Westergren sedimentation rates.
Bucher WC; Gall EP; Woodworth R
Am J Clin Pathol; 1975 Nov; 64(5):613-7. PubMed ID: 1081336
[TBL] [Abstract][Full Text] [Related]
8. Endothelial dysfunction in patients with kidney failure and vascular risk factors: acute effects of hemodialysis.
Migliacci R; Falcinelli F; Imperiali P; Floridi A; Nenci GG; Gresele P
Ital Heart J; 2004 May; 5(5):371-7. PubMed ID: 15185901
[TBL] [Abstract][Full Text] [Related]
9. Erythrocyte sedimentation rate, an underestimated tool in chronic renal failure.
Brouillard M; Reade R; Boulanger E; Cardon G; Dracon M; Dequiedt P; Pagniez D
Nephrol Dial Transplant; 1996 Nov; 11(11):2244-7. PubMed ID: 8941585
[TBL] [Abstract][Full Text] [Related]
10. Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients.
Afzali B; Bakri RS; Bharma-Ariza P; Lumb PJ; Dalton N; Turner NC; Wierzbicki AS; Crook MA; Goldsmith DJ
J Nephrol; 2003; 16(4):540-5. PubMed ID: 14696756
[TBL] [Abstract][Full Text] [Related]
11. The hematocrit-corrected erythrocyte sedimentation rate can be useful in diagnosing inflammation in hemodialysis patients.
Borawski J; Myśliwiec M
Nephron; 2001 Dec; 89(4):381-3. PubMed ID: 11721153
[TBL] [Abstract][Full Text] [Related]
12. Increased plasma levels of mature form of adrenomedullin in patients with chronic renal failure.
Ishihara T; Yokota N; Hisanaga S; Fujimoto S; Hirayama N; Kato J; Kitamura K; Eto T
Clin Nephrol; 1999 Aug; 52(2):119-23. PubMed ID: 10480223
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the Wintrobe, the Westergren and the ZSR erythrocyte sedimentation rate (ESR) methods to a candidate reference method.
Moseley DL; Bull BS
Clin Lab Haematol; 1982; 4(2):169-78. PubMed ID: 7116797
[No Abstract] [Full Text] [Related]
14. Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure.
Mohora M; Mircescu G; Cîrjan C; Mihăilescu I; Gîrneaţă L; Ursea N; Dinu V
Rom J Intern Med; 1995; 33(3-4):237-42. PubMed ID: 8646196
[TBL] [Abstract][Full Text] [Related]
15. Secreted platelet proteins with antiheparin and mitogenic activities in chronic renal failure.
Guzzo J; Niewiarowski S; Musial J; Bastl C; Grossman RA; Rao AK; Berman I; Paul D
J Lab Clin Med; 1980 Jul; 96(1):102-13. PubMed ID: 6446588
[TBL] [Abstract][Full Text] [Related]
16. Zeta sedimentation ratio (ZSR), a replacement for the erythrocyte sedimentation rate (ESR).
Morris MW; Skrodzki Z; Nelson DA
Am J Clin Pathol; 1975 Aug; 64(2):254-6. PubMed ID: 808117
[TBL] [Abstract][Full Text] [Related]
17. Elevated homocysteine levels in patients with end-stage renal disease.
Nair AP; Nemirovsky D; Kim M; Geer EB; Farkouh ME; Winston J; Halperin JL; Robbins MJ
Mt Sinai J Med; 2005 Nov; 72(6):365-73. PubMed ID: 16358160
[TBL] [Abstract][Full Text] [Related]
18. [Erythrocyte deformability in acute and chronic kidney failure patients].
Grinshteĭn IuI; Kalinina IA; Vitman TV
Ter Arkh; 1986; 58(12):91-3. PubMed ID: 3824225
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
[TBL] [Abstract][Full Text] [Related]
20. Red blood cell membrane lipid peroxidation and resistance to erythropoietin therapy in hemodialysis patients.
Gallucci MT; Lubrano R; Meloni C; Morosetti M; Manca di Villahermosa S; Scoppi P; Palombo G; Castello MA; Casciani CU
Clin Nephrol; 1999 Oct; 52(4):239-45. PubMed ID: 10543326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
